ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1149

Phenotypic and Molecular Profile Of Innate Lymphoid Cells In Chronic Synovial Inflammation

Hulda S. Hreggvidsdottir1,2, Maureen C. Turina1, Troy Noordenbos1,3, Marius Munneke4, Charlotte Peters2, Jochem Bernink2, Jenny Mjosberg5, Dominique L. Baeten6 and Hergen Spits2, 1Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Tytgat Institute for Liver and Intestinal Research, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Department of Hematology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 5Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 6Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: inflammatory cytokines, innate immunity, spondylarthritis and synovial cells, synovial fluid, Synovial Immune Biology

  • Tweet
  • Email
  • Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Innate lymphoid cells (ILCs) represent a novel family of effector and regulatory cells in innate immunity and tissue remodelling. The family comprises several phenotypically and functionally distinct subsets that respond rapidly upon stimulation by producing various T helper cell cytokines such as IL-22, IL-17, IFNγ, TNF, IL-13 and IL-5, of which many are shown to be important in arthritis pathogenesis. The IL-17 and IL-22 producing ILCs are of major interest as they are implicated in chronic gut inflammation. Based on the broad clinical overlap between inflammatory bowel disease and spondyloarthritis (SpA) and the clinical importance of IL-17 in SpA we hypothesize that IL-17 and IL-22 producing ILCs contribute to inflammation and remodelling in SpA synovitis. As these cells have never been described in the joint we aimed at characterising ILC in chronic inflammatory arthritis.

Methods: ILCs (lineage negative, CD45+CD127+) were analysed and sorted by flow cytometry from synovial tissue and fluid from rheumatoid arthritis (RA) and SpA patients as well as in blood from SpA patients and healthy donors. mRNA expression of sorted and expanded cells was analysed by qPCR.

Results: ILCs were identified in blood as well as in synovial tissue and fluid from both RA and SpA patients. The frequency of ILCs was higher in the inflamed joint (0,5-3,3% of the lymphocyte population) than in the peripheral blood compartment (0,1%). In the inflamed joint, the ILC3 (CRTH2–NKp44+ckit+) and ILC1 (CRTH2–NKp44–ckit–) populations, shown to express IL-22 and IFNγ respectively in other tissues, were present in all samples whereas the Th2 cytokine expressing ILC2s (CRTH2+) were found in low frequencies. Frequencies of ILC subpopulations varied considerably between patients and no differences could be detected between RA and SpA patients. qPCR analysis of expanded cells from the synovium revealed that ILC1s expressed TBX21 whereas ILC3s expressed RORC. Accordingly, stimulated ILC3s expressed transcripts for both IL-23R and IL-22 but not IL-17. A trend towards higher frequency of total ILC and ILC3s was found in the blood of SpA patients compared to controls.

Conclusion: ILC1s and ILC3s are present in the chronically inflamed joint, are enriched compared to peripheral blood and express the key transcription factors associated with specific cytokine profiles. These data indicate that ILCs could contribute to local cytokine-driven immune alterations in SpA and RA.


Disclosure:

H. S. Hreggvidsdottir,
None;

M. C. Turina,
None;

T. Noordenbos,
None;

M. Munneke,
None;

C. Peters,
None;

J. Bernink,
None;

J. Mjosberg,
None;

D. L. Baeten,
None;

H. Spits,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenotypic-and-molecular-profile-of-innate-lymphoid-cells-in-chronic-synovial-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology